Literature DB >> 1540721

Angiotensin converting enzyme inhibitors and diabetic nephropathy.

C E Mogensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1540721      PMCID： PMC1881226          DOI： 10.1136/bmj.304.6823.327

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  19 in total

1.  Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.

Authors:  E Hommel; H H Parving; E Mathiesen; B Edsberg; M Damkjaer Nielsen; J Giese
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

Review 2.  Kidney disease of diabetes mellitus (diabetic nephropathy): perspectives in the United States.

Authors:  G E Striker; L L Agodoa; P Held; T Doi; F Conti; L J Striker
Journal:  J Diabet Complications       Date:  1991 Apr-Sep

3.  Improved survival in patients with diabetic nephropathy.

Authors:  E R Mathiesen; K Borch-Johnsen; D V Jensen; T Deckert
Journal:  Diabetologia       Date:  1989-12       Impact factor: 10.122

4.  Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy.

Authors:  S Björck; G Nyberg; H Mulec; G Granerus; H Herlitz; M Aurell
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

5.  Prognosis in diabetic nephropathy.

Authors:  H H Parving; E Hommel
Journal:  BMJ       Date:  1989-07-22

6.  Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy.

Authors:  E Morelli; N Loon; T Meyer; W Peters; B D Myers
Journal:  Diabetes       Date:  1990-01       Impact factor: 9.461

7.  Renal protective effect of enalapril in diabetic nephropathy.

Authors:  S Björck; H Mulec; S A Johnsen; G Nordén; M Aurell
Journal:  BMJ       Date:  1992-02-08

8.  Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

Authors:  E R Mathiesen; E Hommel; J Giese; H H Parving
Journal:  BMJ       Date:  1991-07-13

9.  Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.

Authors:  H H Parving; E Hommel; U M Smidt
Journal:  BMJ       Date:  1988-10-29

Review 10.  Renal factors influencing blood pressure threshold and choice of treatment for hypertension in IDDM.

Authors:  C E Mogensen; K W Hansen; M M Pedersen; C K Christensen
Journal:  Diabetes Care       Date:  1991-11       Impact factor: 19.112
View more
  6 in total

1.  Renal protective effect of enalapril in diabetic nephropathy.

Authors:  W W Yeo; L E Ramsay; P R Jackson
Journal:  BMJ       Date:  1992-03-28

Review 2.  Treatment of hypertension in the presence of coexisting medical conditions.

Authors:  J Kvasnicka; J M Flack; R H Grimm
Journal:  Drugs Aging       Date:  1994-04       Impact factor: 3.923

Review 3.  Renoprotective role of ACE inhibitors in diabetic nephropathy.

Authors:  C E Mogensen
Journal:  Br Heart J       Date:  1994-09

4.  Beta 2-glycoprotein-1 (apolipoprotein H) excretion and renal tubular malfunction in diabetic patients without clinical proteinuria.

Authors:  M Lapsley; F V Flynn; P A Sansom
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

Review 5.  Treatment of diabetes mellitus.

Authors:  R P Robertson; D J Klein
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

6.  Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis.

Authors:  J C Chan; C S Cockram; M G Nicholls; C K Cheung; R Swaminathan
Journal:  BMJ       Date:  1992-10-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.